 Sage Therapeutics, Inc. NASDAQ:SAGE Q2 2022 Earnings Conference Call August 2, 2022 8:00 AM ET Company Participants Helen Rubinstein - IR Barry Greene - CEO Albert Robichaud - Chief Scientific Officer Chris Benecchi - Chief Business Officer Kimi Iguchi - CFO Conference Call Participants Ritu Baral - Cowen Paul Matteis - Stifel Ami Fadia - Needham Jay Olson - Oppenheimer Swapnil Malekar - Piper Sandler Yatin Suneja - Guggenheim Marc Goodman - SVB Leerink Gospel Enyindah-Asonye - Morgan Stanley Gary Nachman - BMO Neena Bitritto-Garg - Citi Stephen Mallon - RBC Capital Markets Alex Nackenoff - Raymond James Operator Good morning. Welcome to Sage Therapeutics Second Quarter 2022 Financial Results Conference Call. 